212 related articles for article (PubMed ID: 24084852)
1. [The relevance of biomarkers for personalised medicine].
Großhennig A; Benda N; Koch A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1480-8. PubMed ID: 24084852
[TBL] [Abstract][Full Text] [Related]
2. [Personalised medicine. Aims and challenges].
Bieber T; Broich K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
[TBL] [Abstract][Full Text] [Related]
3. [Special considerations for the regulation of biological medicinal products in individualised medicine. More than stratified medicine].
Müller-Berghaus J; Volkers P; Scherer J; Cichutek K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1538-44. PubMed ID: 24170083
[TBL] [Abstract][Full Text] [Related]
4. The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
Li M; Yu T; Hu YF
Stat Med; 2015 Jun; 34(14):2222-34. PubMed ID: 25779099
[TBL] [Abstract][Full Text] [Related]
5. [Personalised medicine in psychiatry and psychotherapy. A review of the current state-of-the-art in the biomarker-based early recognition of psychoses].
Koutsouleris N; Ruhrmann S; Falkai P; Maier W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1522-30. PubMed ID: 24170081
[TBL] [Abstract][Full Text] [Related]
6. Biostatistic tools in pharmacogenomics--advances, challenges, potential.
Sato Y; Laird NM; Yoshida T
Curr Pharm Des; 2010; 16(20):2232-40. PubMed ID: 20459388
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine: Time for one-person trials.
Schork NJ
Nature; 2015 Apr; 520(7549):609-11. PubMed ID: 25925459
[No Abstract] [Full Text] [Related]
8. [Personalised medicine for the diagnosis and treatment of allergic diseases].
Vieths S; Bieber T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1531-7. PubMed ID: 24170082
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine in children with asthma.
Pijnenburg MW; Szefler S
Paediatr Respir Rev; 2015 Mar; 16(2):101-7. PubMed ID: 25458797
[TBL] [Abstract][Full Text] [Related]
10. [Personalised medicine].
Broich K; Bieber T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1465-7. PubMed ID: 24170074
[No Abstract] [Full Text] [Related]
11. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
12. [Biomarker analysis from a pathologist's view. Founding the rationale for personalised treatment of lung cancer].
Buettner R; Heydt C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1502-8. PubMed ID: 24170079
[TBL] [Abstract][Full Text] [Related]
13. Defining drug response for stratified medicine.
Lonergan M; Senn SJ; McNamee C; Daly AK; Sutton R; Hattersley A; Pearson E; Pirmohamed M
Drug Discov Today; 2017 Jan; 22(1):173-179. PubMed ID: 27818254
[TBL] [Abstract][Full Text] [Related]
14. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
[TBL] [Abstract][Full Text] [Related]
15. Individually tailored immunosuppression: is there a role for biomarkers?
Brandhorst G; Oellerich M; Brunet M; Kowalski R; Vinks A; Wallemacq P
Clin Chem; 2011 Mar; 57(3):376-81. PubMed ID: 21228253
[No Abstract] [Full Text] [Related]
16. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
17. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
[TBL] [Abstract][Full Text] [Related]
18. Does personalized medicine exist and can you test it in a clinical trial?
Sandercock PA
Int J Stroke; 2015 Oct; 10(7):994-9. PubMed ID: 26282857
[TBL] [Abstract][Full Text] [Related]
19. [Importance of bioinformatics in personalised medicine].
Lengauer T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1489-94. PubMed ID: 24170077
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
LLerena A; Peñas-Lledó EM
Drug Metab Pers Ther; 2015 Sep; 30(3):143-5. PubMed ID: 26353178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
